Drug
Capsaicin clinical trials
Also written Qutenza, ALGRX 4975, NGX-4010 and Zostrix.
Includes 1 study of Capsaicin palmitate.
- studies test it
- 105
- open now
- 15
- in phase 3
- 24
- first study started
- 1995
Keep track of what changes. Save the Capsaicin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
99 studies that test it; most in 2016 (8)
| Year | Studies |
|---|---|
| 1995 | 1 |
| 1997 | 1 |
| 1998 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 6 |
| 2006 | 3 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 7 |
| 2011 | 5 |
| 2012 | 6 |
| 2013 | 5 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 8 |
| 2017 | 6 |
| 2018 | 4 |
| 2019 | 7 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 4 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 9
- Phase 1
- 14
- Phase 2
- 33
- Phase 3
- 24
- Phase 4
- 17
- No phase
- 17
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 32 · Other 73
NeurogesX (15) · University of Florida (5) · AlgoRx Pharmaceuticals (5) · The University of Texas Health Science Center, Houston (3) · Universitaire Ziekenhuizen KU Leuven (3) · Astellas Pharma Inc (3) · Institut Cancerologie de l'Ouest (2) · Carilion Clinic (2)
Often tested with
Tested in the same studies.
Diclofenac (2) · Anti-Inflammatory Agents, Non-Steroidal (2) · Cinnamaldehyde (2) · Menthol (2) · Flupirtine (1) · Allyl isothiocyanate (1) · Saline Solution (1) · Transcutaneous Electrical Nerve Stimulation (1)
Studies
Open first, then newest update. How each study uses Capsaicin is read from its arms, and is right about nine times in ten.
Testing it · 105
- Study Evaluating the Analgesic Efficacy of Capsaicin 8% Patches in Chronic Coccygodynia.RecruitingPhase 3Nantes University HospitalNCT06023706Written as Capsaicin 179 Mg Cutaneous Patch
- Marsili Syndrome as a Gateway to Novel Analgesic TargetsNot yet recruitingNot applicableAalborg UniversityNCT07755930Written as Capsaicin 8% Patch
- Transient Receptor Potential ChannelsEnrolling by invitationEarly Phase 1Penn State UniversityNCT06444594Written as TRPV4 Agonist
- Pain Beliefs and Intracortical Excitability During Experimental PainNot yet recruitingNot applicableUniversité de SherbrookeNCT07688525Written as Topical Capsaicin Cream (1%)
- Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Single Center Pilot StudyRecruitingEarly Phase 1M.D. Anderson Cancer CenterNCT06744816Written as Qutenza Patch
- Analgesic Effectiveness of Capsaicin 8% Cutaneous Patch in ChildrenRecruitingPhase 3University Hospital, BrestNCT05997979Written as Capsaicin 8% patch
- Chemotherapy Induced Peripheral Neuropathy by Taxanes and Capsaicin 8%.RecruitingNot applicableHospital Ambroise Paré ParisNCT07602387Written as Capsaicin 8% Patch
- Efficacy of a Topical Palmitated Formulation of Capsaicin (Capsadyn®) In the Treatment of Diabetic Neuropathic Foot PainRecruitingEarly Phase 1Carilion ClinicNCT07260656Written as Capsaicin Palmitate
- Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral NeuropathyRecruitingPhase 3Institut Cancerologie de l'OuestNCT05840562Written as Capsaicin
- Pain Biomarker StudyEnrolling by invitationPhase 1The University of Texas Health Science Center, HoustonNCT03511846Written as Oral capsaicin
- Capsaicin in Digital Osteoarthritis Versus ControlRecruitingPhase 4University Hospital, Clermont-FerrandNCT06444919Written as Capsaicin 179 Mg Cutaneous Patch
- Acute Effect of Capsimax on Resistance Exercise Performance, Muscle Oxygenation, Nitric Oxide Release, Resting Energy Expenditure and Reaction TimeNot yet recruitingNot applicableHofstra UniversityNCT06612658Written as A novel, proprietary encapsulated form of Capsicum extract in beadlet form standardized to 2% capsaicinoids
- Qutenza Versus Duloxetine in Chemotherapy-induced Peripheral Neuropathy (CIPN)RecruitingNot applicableAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)NCT05560516Written as Qutenza
- Effects of 6-month of Treatment With TRPV1 and TRPA1 Agonists in Older Patients With ODNot yet recruitingNot applicableHospital de MataróNCT05958173Written as Capsaicin
- Capsaicin for Post-stroke DysphagiaRecruitingPhase 2Georg Kägi, MDNCT04470752Written as Capsaicin 1% oral solution
- Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After SurgeryCompletedPhase 3Averitas Pharma, Inc.NCT04967664Written as Qutenza (capsaicin) 8% topical system
- Evaluation in the Treatment of Neuropathic Pain Post Breast SurgeryCompletedPhase 3Institut Cancerologie de l'OuestNCT03794388Written as Capsaicin
- Study to Evaluate the Interest of Qutenza in Patients With Head and Neck Cancer in Remission and With Sequelae Neuropathic Pain.CompletedPhase 2Institut Claudius RegaudNCT04704453Written as Capsaïcin patch (Qutenza®)
- Peripheral KV7 Activation for Pain ReliefCompletedEarly Phase 1Stefan HeberNCT06971250Written as Capsaicin + Flupirtine 0.5 µg
- Phase I/II Randomized, Placebo-Controlled Study of Capsaicin for Interstitial Cystitis and Vulvar VestibulitisCompletedPhase 1/2National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT00004316Written as capsaicin
See all 105 studies that test Capsaicin →
Given in every arm · 7 — Capsaicin is usual care beside what is tested
- Functional Magnetic Resonance Imaging of ATP Cough in Chronic Cough PatientsCompletedNot applicableStuart MazzoneNCT03722849Written as Capsaicin
- Efficacity of a Standardized Hypnotic Message During the Application of a Qutenza (Capsaicin) 8% PatchCompletedPhase 3Institut de Cancérologie de LorraineNCT02822625Written as QUTENZA®
- Evaluation of Peripheral Itch Mechanisms Following Injection of Morphine (Second Sub-Project)CompletedNot applicableAalborg UniversityNCT04700007Written as Capsaicin
- Effect of Spinal Ketorolac After Acute Opioid ExposureTerminatedPhase 2Wake Forest UniversityNCT00693160Written as Capsaicin
- Method of Pre-treatment for Application of QUTENZA Capsaicin 8% PatchCompletedPhase 4Astellas Pharma IncNCT01416116Written as QUTENZA
- Cough and Swallow Rehab Following StrokeCompletedPhase 1/2University of FloridaNCT01907321Written as Measures performed on all subjects
- Experimental Biomarker Study for Pain ThresholdsCompletedPhase 1Purdue Pharma LPNCT02695745Written as Capsaicin
As the comparator · 3 — what is tested is compared with Capsaicin
- Serratus Plane Block (SPB) Versus Capsaïcine Versus Botox-A for Chronic Neuropathic Pain in Post-mastectomy SyndromeWithdrawnPhase 2Centre Oscar LambretNCT06807164Written as Capsaicin 8% Patch
- A Study to Compare Levels of Capsaicin After Intra-Articular Injection and Topical Application in Patients With Painful Knee OsteoarthritisCompletedPhase 1Centrexion TherapeuticsNCT03576508Written as Qutenza
- Study of Capsaicin Patch for the Management of Peripheral Neuropathic PainCompletedPhase 1/2Samyang Biopharmaceuticals CorporationNCT02228928Written as 0.075% capsaicin cream
Codes
What other systems call Capsaicin · ClinicalTrials.gg INT007136
- MeSH (NLM) D002211CapsaicinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) S07O44R1ZMCAPSAICINConfirmed FDA, NLM, Wikidata
- RxNorm 1992Confirmed FDA, Wikidata
- Wikidata Q273169capsaicinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C339CapsaicinOne source FDA
- DrugBank DB06774One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D002211 | Capsaicin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | S07O44R1ZM | CAPSAICIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1992 | — | Confirmed FDA, Wikidata |
| Wikidata | Q273169 | capsaicin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C339 | Capsaicin | One source FDA |
| DrugBank | DB06774 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.